<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0248103.ref098">
 <label>98</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>You</surname>
   <given-names>HL</given-names>
  </name>, 
  <name>
   <surname>Liu</surname>
   <given-names>TT</given-names>
  </name>, 
  <name>
   <surname>Weng</surname>
   <given-names>SW</given-names>
  </name>, 
  <name>
   <surname>Chen</surname>
   <given-names>CH</given-names>
  </name>, 
  <name>
   <surname>Wei</surname>
   <given-names>YC</given-names>
  </name>, 
  <name>
   <surname>Eng</surname>
   <given-names>HL</given-names>
  </name>, 
  <etal>et al</etal>. 
  <article-title>Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma</article-title>. 
  <source>Oncol Lett</source>. 
  <year>2018</year>; 
  <volume>16</volume>(
  <issue>4</issue>): 
  <fpage>5505</fpage>â€“
  <lpage>11</lpage>. 
  <pub-id pub-id-type="doi">10.3892/ol.2018.9284</pub-id>
  <?supplied-pmid 30250623?>
  <pub-id pub-id-type="pmid">30250623</pub-id>
 </mixed-citation>
</ref>
